Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: Paclitaxel-loaded glycyrrhizic acid micelles

Molecules

Volumn 20, Issue 3, 2015, Pages 4337-4356

  Yang, Fu Heng ^a   Zhang, Qing ^a   Liang, Qian Ying ^a   Wang, Sheng Qi ^a   Zhao, Bo Xin ^a   Wang, Ya Tian ^a   Cai, Yun ^a   Li, Guo Feng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Glycyrrhizic acid; Micelles; Oral bioavailability; Paclitaxel

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; DRUG CARRIER; GLYCYRRHIZIC ACID; MICELLE; PACLITAXEL;

ANIMAL; BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; INTESTINE; INTESTINE ABSORPTION; JEJUNUM; MALE; METABOLISM; MICELLE; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; GLYCYRRHIZIC ACID; INTESTINAL ABSORPTION; INTESTINES; JEJUNUM; MALE; MICELLES; PACLITAXEL; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 84928665796     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules20034337     Document Type: Article

References (46)

1. Singla, A.K.; Garg, A.; Aggarwal, D. Paclitaxel and its formulations. Int. J. Pharm. 2002, 235, 179-192.
2. Beijnen, J.H.; Huizing, M.T.; Ten, B.H.W.; Veenhof, C.H.; Vermorken, J.B.; Giaccone, G.; Pinedo, H.M. Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drug paclitaxel (Taxol). Semin Oncol 1994, 21 (Suppl. S8), 53-62.
3. Sparreboom, A.; van Asperen, J.; Mayer, U.; Schinkel, A.H.; Smit, J.W.; Meijer, D.K.; Borst, P.; Nooijen, W.J.; Beijnen, J.H.; van Tellingen, O. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA 1997, 94, 2031-2035.
4. Iqbal, J.; Sarti, F.; Perera, G.; Bernkop-Schnurch, A. Development and in vivo evaluation of an oral drug delivery system for paclitaxel. Biomaterials 2011, 32, 170-175.
5. Chen, R.D.; Ren, F.; Li, G.F.; Liu, S.J. Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles. Nan Fang Yi Ke Da Xue Xue Bao 2010, 30, 763-766.
6. Campos, F.C.; Victorino, V.J.; Martins-Pinge, M.C.; Cecchini, A.L.; Panis, C.; Cecchini, R. Systemic toxicity induced by paclitaxel in vivo is associated with the solvent cremophor EL through oxidative stress-driven mechanisms. Food Chem. Toxicol. 2014, 68, 78-86.
7. Russell-Jones, G.J. Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium. J. Drug Target 2004, 12, 113-123.
8. Nornoo, A.O.; Zheng, H.; Lopes, L.B.; Johnson-Restrepo, B.; Kannan, K.; Reed, R. Oral microemulsions of paclitaxel: In situ and pharmacokinetic studies. Eur. J. Pharm. Biopharm. 2009, 71, 310-317.
9. Kim, S.Y.; Lee, Y.M. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. Biomaterials 2001, 22, 1697-1704.
10. Ruan, G.; Feng, S.S. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 2003, 24, 5037-5044.
11. Cavalli, R.; Caputo, O.; Gasco, M.R. Preparation and characterization of solid lipid nanospheres containing paclitaxel. Eur. J. Pharm. Sci. 2000, 10, 305-309.
12. Yoncheva, K.; Calleja, P.; Agueros, M.; Petrov, P.; Miladinova, I.; Tsvetanov, C.; Irache, J.M. Stabilized micelles as delivery vehicles for paclitaxel. Int. J. Pharm. 2012, 436, 258-264.
13. Dahmani, F.Z.; Yang, H.; Zhou, J.; Yao, J.; Zhang, T.; Zhang, Q. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: Preparation, in vitro and in vivo evaluation. Eur. J. Pharm. Sci. 2012, 47, 179-189.
14. Torne, S.J.; Ansari, K.A.; Vavia, P.R.; Trotta, F.; Cavalli, R. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug Deliv. 2010, 17, 419-425.
15. Khandavilli, S.; Panchagnula, R. Nanoemulsions as versatile formulations for paclitaxel delivery: Peroral and dermal delivery studies in rats. J. Investig. Dermatol. 2007, 127, 154-162.
16. Ramos-Cabrer, P.; Campos, F. Liposomes and nanotechnology in drug development: Focus on neurological targets. Int. J. Nanomedicine 2013, 8, 951-960.
17. Hamman, J.H. Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Mar. Drugs 2010, 8, 1305-1322.
18. Zhao, L.; Li, N.; Wang, K.; Shi, C.; Zhang, L.; Luan, Y. A review of polypeptide-based polymersomes. Biomaterials 2014, 35, 1284-1301.
19. Fiore, C.; Eisenhut, M.; Ragazzi, E.; Zanchin, G.; Armanini, D. A history of the therapeutic use of liquorice in Europe. J. Ethnopharmacol. 2005, 99, 317-324.
20. Shibata, S. A drug over the millennia: Pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 2000, 120, 849-862.
21. Selyutina, O.Y.; Polyakov, N.E.; Korneev, D.V.; Zaitsev, B.N. Influence of glycyrrhizin on permeability and elasticity of cell membrane: Perspectives for drugs delivery. Drug Deliv. 2014, 1-8, doi:10.3109/10717544.2014.919544.
22. Zhao, M.X.; Ji, L.N.; Mao, Z.W. beta-Cyclodextrin/glycyrrhizic acid functionalised quantum dots selectively enter hepatic cells and induce apoptosis. Chemistry 2012, 18, 1650-1658.
23. Chen, L.; Yang, J.; Davey, A.K.; Chen, Y.X.; Wang, J.P.; Liu, X.Q. Effects of diammonium glycyrrhizinate on the pharmacokinetics of aconitine in rats and the potential mechanism. Xenobiotica 2009, 39, 955-963.
24. Radwant, M.A.; Aboul-Enein, H.Y. The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J. Microencapsul. 2002, 19, 225-235.
25. James, K.C.; Stanford, J.B. The solubilising properties of liquorice. J. Pharm. Pharmacol. 1962, 14, 445-450.
26. Kornievskaya, V.S.; Kruppa, A.I.; Polyakov, N.E.; Leshina, T.V. Effect of glycyrrhizic acid on lappaconitine phototransformation. J. Phys. Chem. B 2007, 111, 11447-11452.
27. Vervaet, C.; Byron, P.R. Drug-surfactant-propellant interactions in HFA-formulations. Int. J. Pharm. 1999, 186, 13-30.
28. Yoshida, N.; Koizumi, M.; Adachi, I.; Kawakami, J. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. Food Chem. Toxicol. 2006, 44, 2033-2039.
29. Yang, J.; Peng, R.X.; Kong, R.; Yu, J.P. Effects of 18 alpha-glycyrrhizic acid on rat liver cytochrome P450 isoenzymes and phase II transferase. Yao Xue Xue Bao 2001, 36, 321-324.
30. Tolstikova, T.G.; Khvostov, M.V.; Bryzgalov, A.O. The complexes of drugs with carbohydrate-containing plant metabolites as pharmacologically promising agents. Mini Rev. Med. Chem. 2009, 9, 1317-1328.
31. Nafisi, S.; Manouchehri, F.; Bonsaii, M. Study on the interaction of glycyrrhizin and glycyrrhetinic acid with RNA. J. Photochem. Photobiol. B 2012, 111, 27-34.
32. Zhu, H.; McShane, M.J. Loading of hydrophobic materials into polymer particles: Implications for fluorescent nanosensors and drug delivery. J. Am. Chem. Soc. 2005, 127, 13448-13449.
33. Kim, J.Y.; Kim, S.; Papp, M.; Park, K.; Pinal, R. Hydrotropic solubilization of poorly water-soluble drugs. J. Pharm. Sci. 2010, 99, 3953-3965.
34. Konnova, T.A.; Faizullin, D.A.; Haertle, T.; Zuev, Y.F. beta-casein micelle formation in water-ethanol solutions. Dokl. Biochem. Biophys. 2013, 448, 36-39.
35. Yang, S.C.; Paik, S.Y.; Ryu, J.; Choi, K.O.; Kang, T.S.; Lee, J.K.; Song, C.W.; Ko, S. Dynamic light scattering-based method to determine primary particle size of iron oxide nanoparticles in simulated gastrointestinal fluid. Food Chem. 2014, 161, 185-191.
36. Hu, F.Q.; Wu, X.L.; Du, Y.Z.; You, J.; Yuan, H. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. Eur. J. Pharm. Biopharm. 2008, 69, 117-125.
37. Mignet, N.; Seguin, J.; Ramos, R.M.; Brulle, L.; Touil, Y.S.; Scherman, D.; Bessodes, M.; Chabot, G.G. Development of a liposomal formulation of the natural flavonoid fisetin. Int. J. Pharm. 2012, 423, 69-76.
38. Liang, N.; Sun, S.; Li, X.; Piao, H.; Piao, H.; Cui, F.; Fang, L. alpha-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: Preparation, characterization and in vitro/in vivo evaluations. Int. J. Pharm. 2012, 423, 480-488.
39. Agueros, M.; Ruiz-Gaton, L.; Vauthier, C.; Bouchemal, K.; Espuelas, S.; Ponchel, G.; Irache, J.M. Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur. J. Pharm. Sci. 2009, 38, 405-413.
40. Gaucher, G.; Satturwar, P.; Jones, M.C.; Furtos, A.; Leroux, J.C. Polymeric micelles for oral drug delivery. Eur. J. Pharm. Biopharm. 2010, 76, 147-158.
41. Bian, X.; Liang, S.; John, J.; Hsiao, C.H.; Wei, X.; Liang, D.; Xie, H. Development of PLGA-based itraconazole injectable nanospheres for sustained release. Int. J. Nanomedicine 2013, 8, 4521-4531.
42. Kulkarni, S.A.; Feng, S.S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm. Res. 2013, 30, 2512-2522.
43. Higuchi, T.; Hom, F.S. Phase solubility of solid species formed by magnesium aluminate from aqueous solutions containing sulfate ions. J. Pharm. Sci. 1963, 52, 426-439.
44. Sato, H.; Wang, Y.M.; Adachi, I.; Horikoshi, I. Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. Biol. Pharm. Bull. 1996, 19, 1596-1601.
45. Zhang, W.; Shi, Y.; Chen, Y.; Ye, J.; Sha, X.; Fang, X. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials 2011, 32, 2894-2906.
46. Fetih, G.; Habib, F.; Okada, N.; Fujita, T.; Attia, M.; Yamamoto, A. Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats. J. Control Release 2005, 106, 287-297.